Table 3.
Cell | Resveratrol Concentration/Duration | Effect | Reference |
---|---|---|---|
Female BALB/C nude mice subcutaneously injected 2 × 106 HeLa cells/mL (100 µL/mouse) | 10 mg/kg RSV orally, daily for 28 days | ↓Tumor weight ↑PLSCR1 |
[52] |
C57BL/6 female mice injected with TC-1 (HPV oncogene E6, E7 positive) cells subcutaneously | Injection of RSV intralesionally administrated for 5 days | ↓Tumor size ↑cell cycle arrest ↓Tumor E6 levels ↓Tumor VEGF levels ↓Tumor PCNA levels |
[67] |
Athymic BALB/C nude mice subcutaneously injected 5 × 106 HeLa cells/mouse | 30 mg/kg RSV intragastrically, 3 times/week for 2 weeks (pre-treatment) | ↓Tumor volume ↓Tumor weight ↓STAT3 protein levels ↓MMP-3/13 protein levels ↑E-cadherin ↓N-cadherin protein levels ↓Vimentin protein levels |
[56] |
Female BALB/C nude mice subcutaneously injected 2 × 106 HeLa cells/mouse | 30 mg/kg RSV orally, 3 times/week for 3 weeks | ↓Tumor volume ↓Tumor weight ↓E6/7 mRNA levels ↓E6/7 protein levels ↑p53 expression ↑Rb1 expression |
[69] |
Female BALB/C nude mice subcutaneously injected 2 × 106 HeLa cells/mL (100 µL/mouse) | 15 mg/kg RSV intragastrically, 3 times/week for 5 weeks | ↓Tumor volume ↓Tumor weight ↓E6/7 mRNA levels ↓E6/7 protein levels ↓p-pRb1 ↑p53 expression |
[59] |